NVIGEN Inc.

NVIGEN Inc. is a nanobiotechnology company specializing in multifunctional, molecularly engineered nanoparticles for biomedical and personalized medicine applications.

The company develops advanced nanoparticle-based technologies for sequencing, liquid biopsy, diagnostics, imaging, and targeted delivery, with a strong focus on cancer profiling and precision medicine. Its core platform features proprietary nanoparticle-imaging-delivery technology and a range of branded product lines. These include MagVigenTM magnetic nanoparticles for DNA capture and purification, MyQuVigenTM combinations for imaging and detection, MaxVigenTM multifunctional nanobeads for targeted delivery, and AuVigenTM gold nanoparticles for various sensing and therapeutic applications. NVIGEN also provides customizable nanoparticle services and ready-to-use reagents for diverse applications, including next-generation sequencing and liquid biopsy workflows. The company promotes its NVIGEN XTM precision medicine and cancer biomarker profiling assays, which include tests designed to predict cancer recurrence and guide personalized therapy. NVIGEN's technologies are utilized by researchers globally, supporting advancements in biomedical research, diagnostics, gene and cell therapy, and drug delivery.